229 related articles for article (PubMed ID: 30111774)
21. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
[TBL] [Abstract][Full Text] [Related]
22. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
[TBL] [Abstract][Full Text] [Related]
23. A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.
Danussi C; Coslovi A; Campa C; Mucignat MT; Spessotto P; Uggeri F; Paoletti S; Colombatti A
Glycobiology; 2009 Oct; 19(10):1056-67. PubMed ID: 19528665
[TBL] [Abstract][Full Text] [Related]
24. The Role of Sialyl-Tn in Cancer.
Munkley J
Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
[TBL] [Abstract][Full Text] [Related]
25. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
Seko A; Ohkura T; Ideo H; Yamashita K
Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
[TBL] [Abstract][Full Text] [Related]
26. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
[TBL] [Abstract][Full Text] [Related]
27. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
28. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
[TBL] [Abstract][Full Text] [Related]
29. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
30. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.
Cao Y; Karsten U
Histochem Cell Biol; 2001 Apr; 115(4):349-56. PubMed ID: 11405064
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
Fujita R; Hamano H; Kameda Y; Arai R; Shimizu T; Ota M; Sato D; Kobayashi H; Iwasaki N; Takahata M
Clin Exp Metastasis; 2019 Dec; 36(6):539-549. PubMed ID: 31595388
[TBL] [Abstract][Full Text] [Related]
32. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
33. Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis.
Kristiansen G; Machado E; Bretz N; Rupp C; Winzer KJ; König AK; Moldenhauer G; Marmé F; Costa J; Altevogt P
Lab Invest; 2010 Jul; 90(7):1102-16. PubMed ID: 20351695
[TBL] [Abstract][Full Text] [Related]
34. Production and characterization of a tumor-specific monoclonal antibody ACT19 recognizing an epitope distinctive from sialosyl-Tn on the TAG72 antigen.
Xiang J; Moyana T; Chen Z; Han W; Ping T; Li E
Tumori; 1993 Feb; 79(1):58-65. PubMed ID: 7684540
[TBL] [Abstract][Full Text] [Related]
35. Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
Gidwani K; Nadeem N; Huhtinen K; Kekki H; Heinosalo T; Hynninen J; Perheentupa A; Poutanen M; Carpen O; Pettersson K; Lamminmäki U
J Appl Lab Med; 2019 Nov; 4(3):299-310. PubMed ID: 31659068
[TBL] [Abstract][Full Text] [Related]
36. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
[TBL] [Abstract][Full Text] [Related]
37. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
[TBL] [Abstract][Full Text] [Related]
38. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
[TBL] [Abstract][Full Text] [Related]
39. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
Lima L; Neves M; Oliveira MI; Dieguez L; Freitas R; Azevedo R; Gaiteiro C; Soares J; Ferreira D; Peixoto A; Fernandes E; Montezuma D; Tavares A; Ribeiro R; Castro A; Oliveira M; Fraga A; Reis CA; Santos LL; Ferreira JA
Urol Oncol; 2017 Dec; 35(12):675.e1-675.e8. PubMed ID: 28911924
[TBL] [Abstract][Full Text] [Related]
40. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
MacLean GD; Reddish MA; Koganty RR; Longenecker BM
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]